Regulatory Rumblings

FCC Proposes New Privacy Rules for Broadband Providers

Posted: Apr 1, 2016 12:15pm ET

Yesterday, splitting on party lines, the FCC voted 3-2 to adopt a Notice of Proposed Rulemaking (NPRM) regarding privacy guidelines for broadband Internet Service Providers (ISPs).


The Fight Continues over Berkeley’s Cell Phone Notice Law

Posted: Mar 25, 2016 3:45pm ET

Several weeks ago, ANA filed a “friend of the court” brief in support of a lawsuit challenging the City of Berkeley’s ordinance forcing wireless producers and sellers to provide a point of sale public notice regarding radio frequency safety.


A Poor Prescription for Drug Pricing

Posted: Mar 18, 2016 10:45am ET

Prescription drug advertising has now been thrust forcefully into the Presidential debate.


Shaping the Future of Advertising at the 2016 ANA Advertising Law & Public Policy Conference

Posted: Mar 3, 2016 11:15am ET

We suddenly have reached a major technological, regulatory, and legal inflection point. The legal, regulatory, and self-regulatory framework created for an analog world is struggling mightily to catch up to today’s realities. This year’s ANA Advertising Law & Public Policy Conference will bring together industry leaders and important regulators for an in-depth look at these and many other key ...


The Increasing EU Privacy Squeeze

Posted: Feb 29, 2016 9:30am ET

Negotiators from the United States and the European Union recently reached an agreement on the new Privacy Shield data transfer pact. This agreement replaced the previously invalidated Safe Harbor agreement between the two continents.


The FCC and Internet Privacy

Posted: Feb 23, 2016 3:00pm ET

Sixty privacy and consumer advocates recently urged the Federal Communications Commission (FCC) to become a “brawnier cop on the beat” under its Open Internet “net neutrality” Order. That Order is currently subject to strong legal challenge, with a decision widely expected this spring.


Another Misguided Attack on Prescription Drug Advertising

Posted: Feb 18, 2016 1:00pm ET

Representative Rosa DeLauro (D-CT) has joined the chorus of misguided attacks on direct-to-consumer (DTC) pharmaceutical advertising. Last week she introduced the “Responsibility in Drug Advertising Act,” (H.R.4565), which would restrict DTC advertising of a new drug in the first three years after the drug’s approval.


11th Hour US-EU Deal Protects Online Advertising Industry, But Storm Clouds Ahead

Posted: Feb 5, 2016 2:30pm ET

In a last minute major push to maintain the ability for companies to transfer consumer data between the European Union and the United States, negotiators from both continents finally have come to an agreement – the new “EU-US Privacy Shield.”


On the Road to Morocco

Posted: Feb 4, 2016 9:15am ET

Before the ICANN CEO, Fadi Chehade, leaves ICANN at the end of March, he will preside over his last ICANN meeting in Marrakesh, Morocco starting in early March. The twin projects of Accountability and Transition still loom large, but now the details need to be finalized in order to meet the current timeline.


E.U. Forces American Companies to Play By Its Rules

Posted: Jan 28, 2016 4:15pm ET

It is no mystery that European Union scrutiny of American companies’ business practices has been increasing over the last year. From the way companies pay taxes to how they display information about individuals online, it seems nothing is escaping the watchful eyes of European regulators.